p.R268Q | TCGA-27-1835 | GBM | TCGA | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.0833 |
p.R268Q | DO11208 | GBM | ICGC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.0833 |
p.W245C | TCGA-CM-4743 | COAD | TCGA | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.1944 |
p.W245C | DO8103 | COAD | ICGC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.1944 |
p.R247Q | TCGA-CM-6167 | COAD | TCGA | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.25 |
p.P254S | DO558 | BLCA | ICGC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.6752 |
p.G268E | DO219080 | HNSC | ICGC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.0833 |
p.M242I | DO44696 | LICA | ICGC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.1111 |
p.G258R | DO38192 | STAD | ICGC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7568 |
p.G258R | DO42312 | UCEC | ICGC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7568 |
p.P259T | SIDM00958 | Chronic Myelogenous Leukemia | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7031 |
p.P259T | ACH-000920 | Leukemia | CCLE | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7031 |
p.P259T | CML-T1 | haematopoietic and lymphoid tissue | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7031 |
p.P262L | SIDM00630 | Breast Carcinoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.25 |
p.P262L | MDA-MB-415 | breast | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.25 |
p.P259L | SIDM00369 | Esophageal Squamous Cell Carcinoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | SIDM00592 | Oral Cavity Carcinoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | SIDM00567 | Other Solid Cancers | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | SIDM01691 | Chronic Myelogenous Leukemia | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | ACH-000321 | Leukemia | CCLE | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | ACH-000647 | Esophageal Cancer | CCLE | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | ACH-000776 | Brain Cancer | CCLE | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | ACH-002244 | Head and Neck Cancer | CCLE | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | TE-1 | oesophagus | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | HO-1-N-1 | salivary gland | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.P259L | ONS-76 | central nervous system | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7582 |
p.K251R | SIDM01028 | Esophageal Squamous Cell Carcinoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.6126 |
p.K251R | SIDM00348 | Esophageal Squamous Cell Carcinoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.6126 |
p.K251R | SIDM01446 | Glioblastoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.6126 |
p.K251R | TE-11 | oesophagus | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.6126 |
p.K251R | KYSE-410 | oesophagus | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.6126 |
p.D263Y | SIDM01122 | Non-Small Cell Lung Carcinoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.2222 |
p.D263Y | ACH-000853 | Lung Cancer | CCLE | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.2222 |
p.D263Y | NCI-H661 | lung | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.2222 |
p.D263N | SIDM00703 | Non-Small Cell Lung Carcinoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.2222 |
p.D263N | ACH-000929 | Lung Cancer | CCLE | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.2222 |
p.D263N | NCI-H2110 | lung | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.2222 |
p.E248V | SIDM00500 | Colorectal Carcinoma | GDSC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.2778 |
p.E248V | ACH-000959 | Colon/Colorectal Cancer | CCLE | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.2778 |
p.R247W | NCI-H630 | large intestine | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation rewiring degron network | 0.25 |
p.P254H | CML-T1 | haematopoietic and lymphoid tissue | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7694 |
p.G258E | NCI-H2110 | lung | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7199 |
p.G258V | NCI-H661 | lung | COSMIC | NKFDLYTKCP | CBL_PTK | 250:259 | Mutation altering degron motif | 0.7532 |